BTC involves cancer of the bile ducts and the gallbladder. In its later stages, it becomes difficult to treat because the cancer may have spread out from where it originated or become unsuitable for surgery. Although chemotherapy still plays a role in the treatment of this cancer, there is also the option of immunotherapy as another way of controlling the growth of the tumour. Durvalumab is one such PD-L1 checkpoint inhibitor administered with Gemcitabine and Cisplatin.
How Does The Medicine Strengthen the Immune Response Against BTC?
Cancer cells have the ability to escape from immune surveillance through the production of PD-L1 proteins. The medicine acts to block the PD-L1 protein to prevent interactions between PD-1 and CD80. Through this process, T-cell functions are restored.
Why Is The Medicine Combined with Gemcitabine and Cisplatin?
Mechanisms of Chemotherapy and Immunotherapy Are Different. Gemcitabine and Cisplatin act to disrupt the growth of the cancerous cell and its DNA synthesis; however, Durvalumab 500mg Injection in biliary tract treatment, helps to enhance an immune response. The combination of these drugs provides a more diverse range of treatment for biliary tract cancer.
What Clinical Evidence Supports Durvalumab-Based Treatment?
The TOPAZ-1 Phase III trial assessed the efficacy of the tablet along with Gemcitabine and Cisplatin on patients having advanced BTC. It was observed that the combination showed better overall survival than chemo alone with median overall survival being 12.9 months versus 11.3 months respectively.
What Should Patients Know About Treatment Safety?
Some of the adverse effects of the injection include fatigue, nausea, skin rash, itching and diarrhea. Other serious side effects include those that occur due to immune response involving organs such as lungs, liver, intestines and thyroid gland. However, patients are advised to visit the doctor when these symptoms persist or worsen.
Conclusion
The medicine introduces the aspect of immunotherapy into the treatment of advanced biliary tract cancer together with the use of chemotherapy. It works by inhibiting the activity of PD-L1 as well as activating the immune system. Therefore, it is another way of treating the condition apart from using Gemcitabine and Cisplatin.
FAQs
1. Is the Injection cure biliary tract cancer?
It cannot provide a cure. However, it is used for the management of the disease and helps delay its progression, but all depends on the patient’s condition.
2. How is the medication given?
It is given by intravenous infusion by a qualified medical professional. The 500 mg in the injection stands for the drug strength and not the total amount of the drug to be taken.
